U.S. President Donald Trump has directed federal agencies to assess China's performance under the Phase 1 trade deal that he ...

A live question and answer session will follow the formal presentations. A replay of the call will be available in the ...

WATERTOWN, Mass. - Vigil Neuroscience , Inc. (NASDAQ:VIGL), a clinical-stage biotechnology company, has announced the progression of its Alzheimer’s disease (AD) candidate, VG-3927, into a Phase 2 ...

The FDA has granted fast-track designation to an investigational antisense oligonucleotide to treat individuals with myotonic ...

Former Deputy National Security adviser Victoria Coates analyzes the implications of the cease-fire deal for Gaza and Israel on ‘Fox & Friends Weekend.’ ...

Corvus Pharmaceuticals (CRVS) announced new interim data from the randomized, double-blind, placebo-controlled Phase 1 clinical trial ...

EMotorad completes Phase 1 of Dynem gigafactory, solidifying its position as a global leader in electric mobility.

The Big Pharma is handing China’s Simcere Zaiming an undisclosed upfront payment with the potential of up to $1.05 billion in milestone payments for a phase 1-stage trispecific antibody.

U.S. President Donald Trump has directed federal agencies to assess China's performance under the Phase 1 trade deal that he ...